Cargando…

Rare RNF213 variant in adolescent with moyamoya disease

INTRODUCTION. Moyamoya disease is a progressive steno-occlusive disease of the major intracranial arteries. Affected individuals are at risk for intracranial hemorrhagic or ischemic stroke, cognitive impairment, and developmental delays. Several susceptibility genes have been identified. The p.R4810...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardoso, Ivana, Pinto, Mariana, Araújo, André, Vila-Real, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Viguera Editores (Evidenze Group) 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364026/
https://www.ncbi.nlm.nih.gov/pubmed/36843178
http://dx.doi.org/10.33588/rn.7605.2021392
_version_ 1785076764676980736
author Cardoso, Ivana
Pinto, Mariana
Araújo, André
Vila-Real, Marta
author_facet Cardoso, Ivana
Pinto, Mariana
Araújo, André
Vila-Real, Marta
author_sort Cardoso, Ivana
collection PubMed
description INTRODUCTION. Moyamoya disease is a progressive steno-occlusive disease of the major intracranial arteries. Affected individuals are at risk for intracranial hemorrhagic or ischemic stroke, cognitive impairment, and developmental delays. Several susceptibility genes have been identified. The p.R4810K variant in the RNF213 gene has been identified in 95% of patients with familial moyamoya disease. CASE REPORT. We present the case of a 15-year-old adolescent girl who presented with chief complaints of dysgraphia, lack of coordination in the right hand, with two months of evolution. Cerebral magnetic resonance imaging revealed several ischemic lesions with different rates of evolution and magnetic resonance angiography showed multiple subocclusive stenoses. In the study of the sequences of the coding regions and intronic flanking regions (±8 bp) of the RNF213 gene, the variant c.12185G>A, p.(Arg4062Gln) was detected in heterozygosity in the RNF213 gene. This result indicates that the patient is heterozygous for the c.12185G>A, p.(Arg4062Gln) variant in the RNF213 gene. The detected variant has already been reported in the literature as a founder variant in the Asian population, associated with moyamoya syndrome. This variant is described in ClinVar as a variant of unknown clinical significance? Furthermore, it is not described in population databases (dbSNP, ESP, gnomAD). CONCLUSION. To our knowledge, the p.(Arg406262Gln) variant has been reported in three Japanese moyamoya disease patients and one European. Therefore, our patient was the second European moyamoya disease patient with this variant identified.
format Online
Article
Text
id pubmed-10364026
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Viguera Editores (Evidenze Group)
record_format MEDLINE/PubMed
spelling pubmed-103640262023-07-25 Rare RNF213 variant in adolescent with moyamoya disease Cardoso, Ivana Pinto, Mariana Araújo, André Vila-Real, Marta Rev Neurol Case Report INTRODUCTION. Moyamoya disease is a progressive steno-occlusive disease of the major intracranial arteries. Affected individuals are at risk for intracranial hemorrhagic or ischemic stroke, cognitive impairment, and developmental delays. Several susceptibility genes have been identified. The p.R4810K variant in the RNF213 gene has been identified in 95% of patients with familial moyamoya disease. CASE REPORT. We present the case of a 15-year-old adolescent girl who presented with chief complaints of dysgraphia, lack of coordination in the right hand, with two months of evolution. Cerebral magnetic resonance imaging revealed several ischemic lesions with different rates of evolution and magnetic resonance angiography showed multiple subocclusive stenoses. In the study of the sequences of the coding regions and intronic flanking regions (±8 bp) of the RNF213 gene, the variant c.12185G>A, p.(Arg4062Gln) was detected in heterozygosity in the RNF213 gene. This result indicates that the patient is heterozygous for the c.12185G>A, p.(Arg4062Gln) variant in the RNF213 gene. The detected variant has already been reported in the literature as a founder variant in the Asian population, associated with moyamoya syndrome. This variant is described in ClinVar as a variant of unknown clinical significance? Furthermore, it is not described in population databases (dbSNP, ESP, gnomAD). CONCLUSION. To our knowledge, the p.(Arg406262Gln) variant has been reported in three Japanese moyamoya disease patients and one European. Therefore, our patient was the second European moyamoya disease patient with this variant identified. Viguera Editores (Evidenze Group) 2023-03-01 /pmc/articles/PMC10364026/ /pubmed/36843178 http://dx.doi.org/10.33588/rn.7605.2021392 Text en Copyright: © Revista de Neurología https://creativecommons.org/licenses/by-nc-nd/4.0/Revista de Neurología trabaja bajo una licencia Creative Commons
spellingShingle Case Report
Cardoso, Ivana
Pinto, Mariana
Araújo, André
Vila-Real, Marta
Rare RNF213 variant in adolescent with moyamoya disease
title Rare RNF213 variant in adolescent with moyamoya disease
title_full Rare RNF213 variant in adolescent with moyamoya disease
title_fullStr Rare RNF213 variant in adolescent with moyamoya disease
title_full_unstemmed Rare RNF213 variant in adolescent with moyamoya disease
title_short Rare RNF213 variant in adolescent with moyamoya disease
title_sort rare rnf213 variant in adolescent with moyamoya disease
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364026/
https://www.ncbi.nlm.nih.gov/pubmed/36843178
http://dx.doi.org/10.33588/rn.7605.2021392
work_keys_str_mv AT cardosoivana rarernf213variantinadolescentwithmoyamoyadisease
AT pintomariana rarernf213variantinadolescentwithmoyamoyadisease
AT araujoandre rarernf213variantinadolescentwithmoyamoyadisease
AT vilarealmarta rarernf213variantinadolescentwithmoyamoyadisease